Integral Diagnostics Limited (OTCMKTS:ITGDF) Shares Shorted: Short Interest Down 74.3% in September

Integral Diagnostics Limited (OTCMKTS:ITGDF) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 192,612 shares, a decrease of 74.3% from the August 31st total of 748,355 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ? days.

Integral Diagnostics Price Performance

Shares of ITGDF remained flat at $1.00 during mid-day trading on Friday. The firm has a 50-day moving average price of $1.00 and a two-hundred day moving average price of $1.02. Integral Diagnostics has a 12 month low of $0.81 and a 12 month high of $3.15.

About Integral Diagnostics

Integral Diagnostics (OTCMKTS:ITGDF) is an Australia-based provider of comprehensive diagnostic imaging services, operating a network of advanced medical imaging facilities across Australia and New Zealand. The company offers a broad range of radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, nuclear medicine, positron emission tomography (PET) scanning and interventional radiology. Integral Diagnostics supports both hospital-based and standalone imaging centres, catering to a diverse patient base that includes outpatient clinics, public hospitals and private practitioners.

Founded through the consolidation of several independent radiology practices, Integral Diagnostics took its current form following an initial public offering on the Australian Securities Exchange in 2013.